| 1 |
35142908 | Relative remission rates of Janus kinase inhibitors in comparison with adalimumab in patients with active rheumatoid arthritis: a network meta-analysis. | 2022 Feb 10 |
2 |
| 2 |
35368750 | Effects and Safety of the Tripterygium Glycoside Adjuvant Methotrexate Therapy in Rheumatoid Arthritis: A Systematic Review and Meta-Analysis. | 2022 |
1 |
| 3 |
35448527 | Serum Cholesteryl Ester Transfer Protein (CETP) and Sortilin (SORT) in Patients with Psoriasis with Relation to Systemic Treatment. | 2022 Apr 9 |
1 |
| 4 |
35466929 | Sex-differential downregulation of methotrexate on plasma viscosity and whole blood viscosity in psoriasis. | 2022 Apr 19 |
3 |
| 5 |
33185166 | Predictors of Cardiovascular Affection in Patients with Active Rheumatoid Arthritis: Secondary Analysis of a Randomized Controlled Trial. | 2021 |
1 |
| 6 |
33269654 | Methotrexate-associated lymphoproliferative disorder with histopathological features of histiocytic necrotizing lymphadenitis. | 2021 Jan |
2 |
| 7 |
33413588 | Connective tissue remodelling is differently modulated by tocilizumab versus methotrexate monotherapy in patients with early rheumatoid arthritis: the AMBITION study. | 2021 Jan 7 |
2 |
| 8 |
33452004 | Filgotinib in combination with methotrexate or as monotherapy versus methotrexate monotherapy in patients with active rheumatoid arthritis and limited or no prior exposure to methotrexate: the phase 3, randomised controlled FINCH 3 trial. | 2021 Jan 15 |
2 |
| 9 |
33605405 | Should we use glucocorticoids in early rheumatoid arthritis? Results at 5 years from the early RA UCLouvain Brussels cohort. | 2021 Dec 1 |
1 |
| 10 |
33645073 | [Meta-analysis of efficacy and safety of sinomenine combined with methotrexate in treatment of rheumatoid arthritis]. | 2021 Jan |
1 |
| 11 |
34385364 | Efficacy and safety of filgotinib in methotrexate-naive patients with rheumatoid arthritis with poor prognostic factors: post hoc analysis of FINCH 3. | 2021 Aug |
1 |
| 12 |
34429160 | Differences and similarities in clinical and functional responses among patients receiving tofacitinib monotherapy, tofacitinib plus methotrexate, and adalimumab plus methotrexate: a post hoc analysis of data from ORAL Strategy. | 2021 Aug 24 |
3 |
| 13 |
34731780 | Methotrexate as a safe immunosuppressive agent during the COVID-19 pandemic. | 2021 Dec |
1 |
| 14 |
34941113 | Clinical efficacy and safety of methotrexate compared with leflunomide in the treatment of rheumatoid arthritis: A protocol for systematic review and meta-analysis. | 2021 Dec 23 |
1 |
| 15 |
32043726 | Efficacy of methotrexate in polymyalgia rheumatica in routine rheumatology clinical care. | 2020 Sep |
1 |
| 16 |
32371387 | Implication of baseline levels and early changes of C-reactive protein for subsequent clinical outcomes of patients with rheumatoid arthritis treated with tocilizumab. | 2020 Jul |
1 |
| 17 |
32508991 | Inflammatory marker alteration in response to systemic therapies in psoriasis. | 2020 Jul |
2 |
| 18 |
32969158 | The impact of single nucleotide polymorphisms in ADORA2A and ADORA3 genes on the early response to methotrexate and presence of therapy side effects in children with juvenile idiopathic arthritis: Results of a preliminary study. | 2020 Nov |
1 |
| 19 |
33138014 | The Effectiveness and Retention Rate of Iguratimod in Japanese Rheumatoid Arthritis Patients with/without Methotrexate in Daily Medical Care. | 2020 Oct 29 |
3 |
| 20 |
30642376 | The value of the simplified RAMRIS-5 in early RA patients under methotrexate therapy using high-field MRI. | 2019 Jan 14 |
1 |
| 21 |
30702995 | Anticytokine Agents: Targeting Interleukin Signaling Pathways for the Treatment of Atherothrombosis | 2019 Feb |
1 |
| 22 |
31110572 | Values and Correlations between C-Reactive Protein and Apolipoprotein B after Treatment with Methotrexate at Patients with Rheumatoid Arthritis. | 2019 Apr 30 |
5 |
| 23 |
31130260 | Upadacitinib as monotherapy in patients with active rheumatoid arthritis and inadequate response to methotrexate (SELECT-MONOTHERAPY): a randomised, placebo-controlled, double-blind phase 3 study. | 2019 Jun 8 |
1 |
| 24 |
31353421 | The longitudinal effect of biologic use on patient outcomes (disease activity, function, and disease severity) within a rheumatoid arthritis registry. | 2019 Nov |
1 |
| 25 |
31602920 | [Meta-analysis of laboratory index of Tripterygium Glycosides Tablets in treatment of rheumatoid arthritis]. | 2019 Aug |
1 |
| 26 |
29214785 | Clinical Outcomes of Low-Dose Methotrexate Therapy as a Second-Line Drug for Intravenous Immunoglobulin-Resistant Kawasaki Disease. | 2018 Jan |
1 |
| 27 |
29599672 | The effect of subcutaneous methotrexate on markers of metabolic syndrome in psoriatic patients - preliminary report. | 2018 Feb |
1 |
| 28 |
29657830 | Conversion to seronegative status after abatacept treatment in patients with early and poor prognostic rheumatoid arthritis is associated with better radiographic outcomes and sustained remission: post hoc analysis of the AGREE study. | 2018 |
1 |
| 29 |
30516330 | A single-center experience with methotrexate in the treatment of Chinese Crohn's disease patients. | 2018 Dec |
1 |
| 30 |
25367713 | Evaluating drug-free remission with abatacept in early rheumatoid arthritis: results from the phase 3b, multicentre, randomised, active-controlled AVERT study of 24 months, with a 12-month, double-blind treatment period. | 2015 Jan |
1 |
| 31 |
24422992 | Changes in C-reactive protein in patients with moderate-to-severe psoriasis switched to adalimumab therapy after suboptimal response to etanercept, methotrexate or phototherapy. | 2014 Dec |
1 |
| 32 |
25005327 | Efficacy of golimumab plus methotrexate in methotrexate-naïve patients with severe active rheumatoid arthritis. | 2014 Sep |
2 |
| 33 |
25204405 | Assessment of the relationship between methotrexate polyglutamates in red blood cells and clinical response in patients commencing methotrexate for rheumatoid arthritis. | 2014 Dec |
2 |
| 34 |
25269199 | [Evaluation of methotrexate effect on the acute-phase response in rheumatoid arthritis after 12-week treatment]. | 2014 |
1 |
| 35 |
23754245 | Reduction of plasma IL-6 but not TNF-α by methotrexate in patients with early rheumatoid arthritis: a potential biomarker for radiographic progression. | 2013 Nov |
2 |
| 36 |
22984272 | Infliximab is associated with improvement in arterial stiffness in patients with early rheumatoid arthritis -- a randomized trial. | 2012 Dec |
1 |
| 37 |
21263416 | Adenosine deaminase and C-reactive protein in diagnosing and monitoring of rheumatoid arthritis. | 2011 Feb |
1 |
| 38 |
21352592 | Adalimumab reduces hand bone loss in rheumatoid arthritis independent of clinical response: subanalysis of the PREMIER study. | 2011 Feb 27 |
1 |
| 39 |
21708910 | Changes in patient characteristics in anti-tumour necrosis factor clinical trials for rheumatoid arthritis: results of an analysis of the literature over the past 16 years. | 2011 Sep |
3 |
| 40 |
21885491 | Abatacept plus methotrexate provides incremental clinical benefits versus methotrexate alone in methotrexate-naive patients with early rheumatoid arthritis who achieve radiographic nonprogression. | 2011 Nov |
1 |
| 41 |
20132066 | Time to methotrexate treatment in patients with rheumatoid arthritis referred to hospital. | 2010 |
2 |
| 42 |
19487269 | E-selectin, interleukin 18, serum amyloid a, and matrix metalloproteinase 9 are associated with clinical response to golimumab plus methotrexate in patients with active rheumatoid arthritis despite methotrexate therapy. | 2009 Jul |
1 |
| 43 |
19827168 | Genetic polymorphisms in folate pathway enzymes as a possible marker for predicting the outcome of methotrexate therapy in Japanese patients with rheumatoid arthritis. | 2009 Jun |
1 |
| 44 |
19951408 | A multicenter, double-blind, randomized, controlled phase III clinical trial of chicken type II collagen in rheumatoid arthritis. | 2009 |
1 |
| 45 |
18271807 | Steroid-resistant adult-onset Still's disease which showed a quick response to methotrexate. | 2008 Feb |
1 |
| 46 |
18972590 | Low-dose methotrexate therapy for intravenous immunoglobulin-resistant Kawasaki disease. | 2008 Oct 31 |
2 |
| 47 |
17963163 | Soluble cell adhesion molecules (sICAM-1, sVCAM-1, and sE-selectin) in patients with early rheumatoid arthritis. | 2007 Sep-Oct |
2 |
| 48 |
16508926 | Predictors of joint damage in patients with early rheumatoid arthritis treated with high-dose methotrexate with or without concomitant infliximab: results from the ASPIRE trial. | 2006 Mar |
1 |
| 49 |
16870092 | Treatment continuation rate in relation to efficacy and toxicity in long-term therapy with low-dose methotrexate, sulfasalazine, and bucillamine in 1,358 Japanese patients with rheumatoid arthritis. | 2006 May-Jun |
1 |
| 50 |
16881109 | Serum matrix metalloproteinases and tissue inhibitors of metalloproteinases in patients with early rheumatoid arthritis. | 2006 Aug |
1 |